Status:
RECRUITING
Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
Lead Sponsor:
Foundation University Islamabad
Conditions:
Bronchial Asthma
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exe...
Detailed Description
Bronchial asthma is a very common chronic disease marked by inflammation and constriction of airways, resulting in recurrent episodes of breathlessness, wheezing and decrease work of breathing. Breath...
Eligibility Criteria
Inclusion
- Adults: aged (18-45 years)
- Gender: Both males and females
- Grade1- Grade 4 on Modified MRC dyspnea scale
- Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin
Exclusion
- Patients having acute exacerbation of COPD or status asthmaticus
- Patients diagnosed with acute infections
- Patients unable to follow command/ instructions
- Asthma patients with \>40 sec control pause duration
- Patients who fall in red zone of asthma action plan (PEFR \< 50%)
Key Trial Info
Start Date :
June 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06609941
Start Date
June 18 2024
End Date
February 1 2025
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Foundation University College of Physical Therapy
Rawalpindi, Punjab Province, Pakistan, 46000